Logo image of NVX

NOVONIX LTD-ADR (NVX) Stock Fundamental Analysis

NASDAQ:NVX - Nasdaq - US67010L1008 - ADR - Currency: USD

1.285  -0.05 (-3.38%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NVX. NVX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While NVX seems to be doing ok healthwise, there are quite some concerns on its profitability. NVX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NVX had negative earnings in the past year.
NVX had a negative operating cash flow in the past year.
NVX had negative earnings in each of the past 5 years.
In the past 5 years NVX always reported negative operating cash flow.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -19.46%, NVX is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
With a Return On Equity value of -29.65%, NVX is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.46%
ROE -29.65%
ROIC N/A
ROA(3y)-14.15%
ROA(5y)-28.77%
ROE(3y)-18.11%
ROE(5y)-50.01%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

NVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NVX has more shares outstanding
NVX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NVX is higher compared to a year ago.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NVX has an Altman-Z score of 0.15. This is a bad value and indicates that NVX is not financially healthy and even has some risk of bankruptcy.
NVX has a worse Altman-Z score (0.15) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that NVX is not too dependend on debt financing.
The Debt to Equity ratio of NVX (0.44) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACCN/A
WACC8.61%
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

NVX has a Current Ratio of 6.15. This indicates that NVX is financially healthy and has no problem in meeting its short term obligations.
NVX has a better Current ratio (6.15) than 87.50% of its industry peers.
NVX has a Quick Ratio of 5.94. This indicates that NVX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NVX (5.94) is better than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 5.94
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.04% over the past year.
The Revenue for NVX has decreased by -17.47% in the past year. This is quite bad
Measured over the past years, NVX shows a very strong growth in Revenue. The Revenue has been growing by 27.36% on average per year.
EPS 1Y (TTM)44.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.75%
Revenue 1Y (TTM)-17.47%
Revenue growth 3Y16.92%
Revenue growth 5Y27.36%
Sales Q2Q%-6.35%

3.2 Future

The Earnings Per Share is expected to decrease by -31.02% on average over the next years. This is quite bad
Based on estimates for the next years, NVX will show a very strong growth in Revenue. The Revenue will grow by 67.12% on average per year.
EPS Next Y16.31%
EPS Next 2Y4.26%
EPS Next 3Y7.41%
EPS Next 5Y-31.02%
Revenue Next Year40.44%
Revenue Next 2Y22.39%
Revenue Next 3Y180.91%
Revenue Next 5Y67.12%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.26%
EPS Next 3Y7.41%

More info and screens

0

5. Dividend

5.1 Amount

NVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVONIX LTD-ADR

NASDAQ:NVX (2/24/2025, 3:26:06 PM)

1.285

-0.05 (-3.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-25 2024-09-25/amc
Earnings (Next)08-20 2025-08-20
Inst Owners6.36%
Inst Owner Change-87.09%
Ins Owners3.07%
Ins Owner ChangeN/A
Market Cap204.12M
Analysts84
Price Target1.88 (46.3%)
Short Float %0.58%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.4%
PT rev (3m)-15.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)26.74%
EPS NY rev (3m)36.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.15
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 1.4
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.05
BVpS1
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.46%
ROE -29.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.15%
ROA(5y)-28.77%
ROE(3y)-18.11%
ROE(5y)-50.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 198.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 5.94
Altman-Z 0.15
F-Score2
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.75%
EPS Next Y16.31%
EPS Next 2Y4.26%
EPS Next 3Y7.41%
EPS Next 5Y-31.02%
Revenue 1Y (TTM)-17.47%
Revenue growth 3Y16.92%
Revenue growth 5Y27.36%
Sales Q2Q%-6.35%
Revenue Next Year40.44%
Revenue Next 2Y22.39%
Revenue Next 3Y180.91%
Revenue Next 5Y67.12%
EBIT growth 1Y23.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.02%
EBIT Next 3Y16.12%
EBIT Next 5Y12.19%
FCF growth 1Y64.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.05%
OCF growth 3YN/A
OCF growth 5YN/A